These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12667288

  • 1. [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].
    Lei XY, Zhang Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):41-4. PubMed ID: 12667288
    [Abstract] [Full Text] [Related]

  • 2. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
    Lei XY, Zhang H, He DM.
    Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
    [Abstract] [Full Text] [Related]

  • 3. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
    Li DL, Lu LH, Chen YY, Lin ZX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
    [Abstract] [Full Text] [Related]

  • 4. Effect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells.
    Zhang Y, Lei XY.
    Hematol J; 2003 Dec; 4(3):187-97. PubMed ID: 12764351
    [Abstract] [Full Text] [Related]

  • 5. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

  • 6. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 16; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 7. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun 16; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

  • 8. Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides.
    Funato T, Kozawa K, Fujimaki S, Kaku M.
    Anticancer Drugs; 2001 Apr 16; 12(4):325-9. PubMed ID: 11335788
    [Abstract] [Full Text] [Related]

  • 9. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K.
    Leukemia; 1996 Nov 16; 10(11):1731-40. PubMed ID: 8892676
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 11. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
    Zhang Y, Shen WL.
    Cell Biol Int; 2003 Oct 15; 27(12):953-8. PubMed ID: 14642526
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.
    Mol Urol; 2001 Oct 15; 5(2):71-8. PubMed ID: 11690551
    [Abstract] [Full Text] [Related]

  • 13. Antisense inhibition of Bax mRNA increases survival of terminally differentiated HL60 cells.
    Manfredini R, Capobianco ML, Trevisan F, Rauzi F, Barbieri D, Citro G, Tagliafico E, Ferrari S.
    Antisense Nucleic Acid Drug Dev; 1998 Aug 15; 8(4):341-50. PubMed ID: 9743471
    [Abstract] [Full Text] [Related]

  • 14. The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines.
    Baśkiewicz-Masiuk M, Masiuk M, Machaliński B.
    Cell Prolif; 2003 Oct 15; 36(5):265-78. PubMed ID: 14521520
    [Abstract] [Full Text] [Related]

  • 15. Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells.
    Fei J, Zhang Y.
    Cell Biol Int; 2005 Sep 15; 29(9):737-41. PubMed ID: 15985377
    [Abstract] [Full Text] [Related]

  • 16. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K, Kim R, Inoue H, Emi M, Uchida Y, Toge T.
    Int J Oncol; 2003 Apr 15; 22(4):875-81. PubMed ID: 12632082
    [Abstract] [Full Text] [Related]

  • 17. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 15; 24(12):640-3. PubMed ID: 14761612
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of Bcl-2 expression in HL60 cells by incubation with antisense phosphorothioate oligodeoxynucleotides].
    Lin Y, Lu L, Hu J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb 10; 16(1):12-5. PubMed ID: 9949233
    [Abstract] [Full Text] [Related]

  • 19. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells].
    He YW, Bian L, Liang XH.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr 10; 22(2):112-4. PubMed ID: 15190790
    [Abstract] [Full Text] [Related]

  • 20. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells].
    Huang YY, Xia Y, Guo HX, Li WY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 10; 28(2):204-8. PubMed ID: 18250043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.